Valneva IPO Presentation Deck

Phase 1 of VLA1553 Showed Enduring High Immunogenicity V A Single Shot is Sufficient to Induce High-Titre Neutralizing Antibodies Sustained at Twelve Months Post Vaccination 1000 GMT (G5% CI) 100 10 1 Day 0 Study Arm *ANOVA Arm L vs. M p = 0.0348 Arm L vs. Hp = 0.0020 Valneva - Roadshow Presentation Day 3 Arm L Day 7 Day 14 Arm M Day 28 Arm H Day 84 Day 180 Arm H1 Month 12 April 2021 20

View entire presentation